Save time and get answers to complex questions with AI chat
How much is mebendazole?Abbvie humira patent cliff navigation success?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?What are the most memorable drug brands in oral factor b inhibitors? in united statesAllergan's patent for latisse expired?
The FDA’s Orange Book is short for “Approved Drug Products with Therapeutic Equivalence Evaluations.” It’s a government resource that lists every FDA‑approved drug product and indicates whether a generic version is therapeutically equivalent to the brand/reference product. What you can use it for - Check if a generic is considered substitutable for a given brand or reference drug. - See the therapeutic equivalence (TE) status for a specific dosage form. - Find patent and exclusivity information that might affect when generics can come to market (for brand-name drugs). What the TE codes mean (in brief) - The entry shows a two-letter TE code for each dosage form. The first letter is A or B: - A = therapeutically equivalent to the reference listed drug (generally substitutable). - B = not therapeutically equivalent (not substitutable). - The second letter/refinement further describes the specific dosage form and formulation. The FDA page includes a legend that explains these codes. How to use it - Search by active ingredient, brand name, or manufacturer on the FDA Orange Book site. - Look at the TE code for the exact dosage form you’re using. - If you see a status beginning with A, generic substitution is typically allowed for that product/formulation; a B status means caution or non‑substitution. If you tell me a drug name and dosage form (e.g., “atorvastatin 20 mg tablet”), I can summarize the Orange Book TE status for that exact product, or guide you to the right entry.
Other Questions About Orange :